Sign in
FHTX Stock Price, Chart, Stats & News
Foghorn Therapeutics Inc.
Save
245.42M
Market cap
–
Current P/E
–
Forward P/E
FHTX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 29.78% |
Operating margin | -265.64% |
Pretax margin | -240.33% |
Net margin | -240.33% |
Effective tax rate | – |
ROA | -37.50% |
ROE | 88.31% |
D/E | -0.38x |
Interest coverage ratio | – |
FHTX valuation
P/E | – |
P/S | 8.55x |
P/B | -2.61x |
P/CF | -3.29x |
P/FCF | -3.07x |
P/OCF | -3.29x |
PEG | 1.09x |
EV multiple | -4.17x |
About
Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within the chromatin regulatory system. The company employs its exclusive "Gene Traffic Control" platform to pinpoint, validate, and strategize drug development for specific targets within this complex system.
Similar securities
Based on sector and market capitalization
Report issue